While the growing oncology pipeline offers tremendous potential, the path from clinical development through to commercial launch and patient administration is complex and lined with challenges that can impact product success and access.
Tommy Bramley and Eric Monzon
Advertisement
Articles by Tommy Bramley and Eric Monzon
Advertisement
Latest Updated Articles
Advancing Innovation in Cancer Care: Bringing the Next Wave of Oncology Products to MarketPublished: July 8th 2025 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
2
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
3
FDA Announces New Biosimilar-Targeted Draft Guidance
4
AI Built for Pharma—Out-of-the-Box Wins on Time, Risk, and ROI
5
